tirzepatide diabetes trial outcompetes long-acting insulin in managing type 2 diabetes: a meta-analysis of three phase 3 randomized controlled trials Tirzepatide as Compared with Semaglutide

It usually appears in the first three to five days and tends to be mild to moderate in intensity, nothing like the nausea associated with starting semaglutide or tirzepatide , but uncomfortable enough to notice

Effectiveness Zepbound is potentially more effective for average weight loss than Wegovy based on data from randomised controlled trials

This distinction is important, and your physician should discuss it with you as part of informed consent

The way it works is by triggering receptors in your body

Track progress: Keep a journal or use an app to monitor your food intake, exercise, and weight loss progress

2 Important safety information: Wegovy (semaglutide) is a prescription-only medication for managing obesity